← FDA Drug Approvals (Drugs@FDA)
FOSAPREPITANT DIMEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2020-08-26
Drug application
- FDA Application #
ANDA204025- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FOSAPREPITANT DIMEGLUMINE
- Generic name
- Fosaprepitant Dimeglumine
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2020-08-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown